Opto Circuits (India) Ltd, leading manufacturer of medical diagnostics and interventional products, has posted impressive performance during the year ended March 2007. The consolidated net profit increased by 89.5 per cent to Rs 73.25 crore from Rs 38.65 crore in the previous year. Its consolidated net sales increased by 80 per cent to Rs 251.57 crore from Rs 139.78 crore. The board has declared equity dividend of 50 per cent for the year 2006-07.

The earning per share, after considering enhance equity capital resulted from liberal bonus issue of 1:1 and public issue, worked out to Rs 11.89 as against Rs 7.21. The equity capital increased to Rs 61.62 crore from Rs 26.81 crore in the previous year. The company issued 40 lakh equity shares of Rs 10 each to public in the Follow on Public Offering during April 2006.

Vinod Ramnani, chairman & managing director, said, "The company has obtained Conformite Europpeen accreditation for its 'DIOR' a pioneering paclitaxel eluting balloon dilation catheter used in PTCA procedures. DIOR has been successfully launched in Europe and is in the process of registration of DIOR in India and the Far East. DIOR is being launched in India his quarter. We are also planning to start clinical trials in USA this quarter for both DIOR and magical product."